SPMMF yields 224.72% · JNJ yields 2.13%● Live data
📍 SPMMF pulled ahead of the other in Year 1
Combined, SPMMF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SPMMF + JNJ for your $10,000?
Space-Communication Ltd. provides satellite communication services worldwide. The company offers on-the-move connectivity solutions; satellite broadband services, including high-speed two-way internet, broadband internet access, B2B and B2C, point-to-multipoint streaming, congestion-free IP trunking, and on-demand services; and satellite broadcasting services, such as DTH and TV/audio origination and distribution, redundancy and backup, encryption, satellite news gathering, video signals packaging and up-linking, TV channels retransmission, and satellite TV programs broadcasting services. It also provides hybrid cellular-satellite internet solutions; cross-region connectivity services; and satellite teleport services. In addition, the company offers corporate and government network solutions comprising local area network interconnection, VSAT network, satellite VPN, and data transmission services, as well as delivery of video, voice, and data to remote locations, including videoconference, telephony, fax transmissions, etc. Further, it provides point of sale applications, such as ATM and inventory reports; and internet applications. The company was founded in 1989 and is based in Ramat Gan, Israel. Space-Communication Ltd. is a subsidiary of Eurocom Holdings (1979) Ltd.
Full SPMMF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.